"This product will solve the problems that have plagued the industry for more than 30 years, and will also advance artificial blood vessels into the six-millimeter era..."

On the stage, Xu Qiu's voice was steady and calm, revealing a sophistication and calmness that belied his age.

Old tools like Wang Shengde and Academician Chen have long been accustomed to this.

Fu Qing and other leaders were shocked.

Not the kind of nerd who only does scientific research?

Daxia has found a treasure!

…

"After discussions between me and the scientific researchers of Linhai University Research Institute, the new artificial blood vessel will be named 'Linhai', the full name is Linhai small-diameter artificial blood vessel..."

Soon, Xu Qiu revealed the first answer.

Yang Chenxi, Ren Chao and others sighed slightly.

Where was this discussed with us?

During the meeting at that time, the entire institute wanted to name it after "Xu's small-diameter artificial blood vessel".

The researchers involved in the study knew very well that without Xu Qiu, they might not have been able to come up with this product in ten or twenty years.

There is no hope at all!

Xu Qiu has already built the framework of the new blood vessel. What they, the scientific researchers, have to do is to carry out experiments and research according to Xu Qiu's plan...

Apart from Xu Qiu, where else can you find a boss who can give you a plan, tell you how to conduct experiments, and pay you an extremely generous salary?

To put it mildly.

Except for Yang Chenxi, who brought the equipment, everyone present was replaced. He just went to major scientific research institutes to recruit a group of corresponding scientific researchers, and this thing could be made.

But if Xu Qiu is replaced, no one can succeed.

However, Xu Qiu didn't seem to be interested in these false names, and left the naming rights to Linhai City.

In the auditorium, the mayor of Linhai City and Fu Qing both looked surprised.

They didn't expect that it would turn out to be this name.

This is equivalent to letting the whole world know that there is a city called Linhai in Baiyun Province in Daxia!

Within Daxia, Tiandu, Magic City, Yangcheng, and Pengcheng are the four major international cities.

Other provinces, cities, and presence are not too strong.

Linhai City may be able to take this opportunity to increase its reputation in the international community, and the benefits will definitely be immeasurable.

As for Baiyun Province, which is at the next level, the benefits will only be greater.

…

"Second, price."

"Taking into account R&D funding, payback cycle, etc..."

“The preliminary domestic pricing is the same as the previous 8mm caliber artificial blood vessels, with an average price of 30,000 yuan.

The selling price abroad is between 60,000 and 120,000 yuan.”

As soon as these words came out, the auditorium suddenly became lively.

Everyone was extremely excited.

Thirty thousand yuan!

Originally, they thought that the price of small-diameter blood vessels in China would at least double, costing at least 60,000 yuan.

However, Xu Qiu set the price at 30,000.

This is the price before medical insurance... After medical insurance is involved, it will only be lower.

Everyone present is a smart person, so they naturally understand what this pricing means.

With an investment of 600 million yuan and a market of 10 billion yuan, if the average selling price is 60,000 yuan, this product can quickly recover its capital through global monopoly and start making profits.

However, Xu Qiu cut the price in half and set it at 30,000.

Although this price can still make a lot of money thanks to the huge market, this is Xu Qiushi's real benefit to the people.

For foreign prices, the price of 60,000 to 120,000 should be the normal price!

"This is truly domestically produced. It doesn't make the common people a penny more..."

"Thirty thousand, I never thought it would be thirty thousand. Even if it is sixty thousand or ninety thousand, this blood vessel is good news to those who have lost hope of treatment!"

"More than 600,000 patients who need vascular reconstruction every year are waiting in vain. Linhai small-diameter artificial blood vessels are their only hope. As a result, it only costs 30,000 yuan in China! If there is a chance to be included in medical insurance, it will be even lower!

"

At this time, the director of the National Health Commission and the director of the Food and Drug Administration also looked surprised.

Thirty thousand is a discount reserved for Daxia’s own people.

For foreign countries, the amount of 60,000 to 120,000 leaves a buffer range for subsequent negotiations.ъìqυgΕtv.℃ǒΜ

For example, Daxia needs to increase the price of 8mm McCovi's blood vessels from 30,000 yuan to 10,000 yuan. In exchange, Daxia will also give McCovi a certain discount for this small-diameter blood vessel.

Xu Qiu's step can be said to be watertight...

Isn’t this really a veteran who plays with the market and hangs out at the negotiation table?

…

"The third."

"Following up, Linhai No. 1 Hospital will perform the second, third and fourth small-caliber artificial blood vessel replacement surgeries.

Our hospital will also open applications for clinical application qualifications nationwide.

At present, the first batch of hospitals that are allowed to carry out clinical surgical experiments simultaneously with Linhai No. 1 Hospital have been determined:

Tiandu Fuwai Hospital.

Tiandu Union Medical College Hospital.

West China Hospital of Sichuan Province.

Huazhong University of Science Tongji Hospital, Tongji Medical College."

Off the court, many hospital directors were very excited.

They did not expect that Xu Qiu did not intend to monopolize this technology, but was willing to share it with the whole country!

Everyone is well aware of these four hospitals that were among the first batch of hospitals approved to conduct clinical trials.

Dean Xiehe has been very close to Linhai No. 1 Hospital recently, and he must have reached some kind of py deal a long time ago.

Not to mention Fuwai, Yang Chenxi, Ma Qin, and a bunch of equipment are all from there.

As for Huaxi and Tongji.

The former is because it has made great achievements in the field of vascular transplantation and can be regarded as recruiting high-level colleagues to participate in the experiment, making up for the shortcomings of Linhai No. 1 Hospital, which currently does not have high-level small-diameter transplantation doctors except for Directors Xu Qiu and Zheng.

For the latter, Tongji has a close relationship with Academician Chen, who has a close relationship with Academician Chen and Xu Qiu.

The robotic resection surgery for liver cancer was specially approved by Academician Chen for Linhai First Hospital.

The two families have a mutually beneficial relationship and are a distant and firm alliance.

Many deans are gearing up.

After mastering this surgery and obtaining the small-diameter blood vessels supplied by Linhai Research Institute, their hospital will be able to overtake in this field!

One step is faster, each step is faster, everyone knows this truth.

Therefore, they all made up their mind that when the meeting was over, they would have a good argument with Xu Qiu, the top management of the Cardiac Surgery Department and Linhai No. 1 Hospital. No matter what the cost, they must win this spot!

…

…

The meeting ultimately lasted more than two hours.

The future of Linhai's small-diameter artificial blood vessels was also laid down in Xu Qiu's plain narrative.

In addition to several key points announced by Xu Qiu.

The leaders of the Health Commission, the First Secretary of Baiyun Province, and the Mayor of Linhai City all gave special instructions and proposed to establish an industrial base for this independently developed product to supply the huge market demand in the future.

The medical industry is different from others.

Once the six-millimeter blood vessel is produced, even if its performance is not good, it is destined to become the only choice for all small-diameter blood vessel transplant patients, and there will inevitably be huge market demand.

What's more, the properties of Xu Qiu's products are very good, and they have performed very well in early animal experiments and current human clinical operations.

Therefore, the city, province, and even the country are willing to spend a lot of money and bet heavily.

According to the preliminary plan, the first phase of the artificial blood vessel production plant will cover an area of ​​15,000 square meters and is expected to be completed by the end of this year. It will gradually expand and increase production capacity in the future, ultimately ensuring that the annual output is more than 100,000 sets.

Of course, the investment costs are also extremely staggering.
Chapter completed!